REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).

Pts with HM may have low or delayed specific immune response after usual vaccination due to immune deficiency, associated to the disease or to the therapy. In this real-life study, 235 pts vaccinated with BNTCV (BioNTech Pfizer) were monitored for 2 years, starting 06/20 in a single Institution. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Jean-François, Bonnet, Emmanuel, Velensek, Marion, Wisniewski, Emma, Heraud, Sophie, Boustany, Rania, David, Céleste, Dinet, Jérôme, Sicard, Roland, Daures, Jean-Pierre, Bonifacy, Marion, Mousset, Lysiane, Castelli, Christel, Goffart, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2022
Materias:
Pp14
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529929/
http://dx.doi.org/10.1016/j.htct.2022.09.1221

Ejemplares similares

Ejemplares similares